Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cells
Peter Deng
Audrey Torrest
Kari Pollock
Heather Dahlenburg
Geralyn Annett
Jan A. Nolta
Kyle D. Fink
Keywords：mesenchymal stem cellsneurodegenerative disordersHuntington’s diseasegenetic engineeringbrain derived neurotrophic factor
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 702-705 )